Mohammed Nashawaty practices Hematology. He received awards:"Meaningful Use Stage 1 Certification". Mohammed K. Nashawaty, MD is a published doctor as well. He has 2 publications published. The latest was: Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1093784985 | |
NPPES Provider LastName | NASHAWATY | |
NPPES Provider FirstName | MOHAMMED | |
NPPES Provider ZIPCode | 554352281 | |
NPPES Provider State | MN | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 820.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 57.0 | |
Percent Opioid Claims | 6.95 |
National Provider Identifier [NPI] | 1093784985 |
Last Name Of The Provider | NASHAWATY |
First Name Of The Provider | MOHAMMED |
View All |
Dr. Khalid Mahmud, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Mark D. Sborov, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Priya Kumar, MD | |
Dr. Paul J. Zander, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Bibi S. Khoyratty, MD | |
Dr. Marie E. Steiner, MD | |
Dr. Matthew O. Nwaneri, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Eric L. Weinshel, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Lucy H. Kapur, MD |